The content discusses the impact of genetic therapies on neurology clinics, focusing on conditions like Charcot-Marie-Tooth (CMT) neuropathy. Dr. Nicolas Madigan highlights the potential of genetic treatments for neuromuscular diseases, emphasizing the importance of genetic testing and counseling in patient care. The landscape of treatments for CMT is explored, including drug combinations, gene replacement strategies, and CRISPR-Cas9 approaches. The need for genetic counselors to support patients through testing and treatment decisions is also addressed.
إلى لغة أخرى
من محتوى المصدر
www.medscape.com
الرؤى الأساسية المستخلصة من
by Jim Kling في www.medscape.com 11-07-2023
http://www.medscape.com/viewarticle/998161استفسارات أعمق